1. Pharmacoeconomic Fellowships

   • Vittorio Maio
   • Tammy K. Girts
   • David B. Nash

   Leading Article 23 September 2012 Pages: 795 - 802

   

2. The Impact of Health Economics on Healthcare Delivery

   • Ruth McDonald
   • Alan Haycox
   • Tom Walley

   Commentary 23 September 2012 Pages: 803 - 809

   

3. A Review of the Direct Costs of Rheumatoid Arthritis

   • Deborah P. Lubeck

   Review Article 23 September 2012 Pages: 811 - 818

   

4. The Cost Effectiveness of Stratified Care in the Management of Migraine

   • Paul Williams
   • Andrew J. Dowson
   • James Sawyer

   Original Research Article 23 September 2012 Pages: 819 - 829

   

5. Cost Effectiveness in Canada of a Multidrug Prepackaged Regimen (Hp-PAC®) for Helicobacter pylori Eradication

   • Karen Agro
   • Gordon Blackhouse
   • Bernie J. O’Brien

   Original Research Article 23 September 2012 Pages: 831 - 843

   

6. Incremental Cost Analysis of Ambulatory Clinic and Home-Based Intravenous Therapy for Patients with Multiple Myeloma

   • Peter C. Coyte
   • Mark J. Dobrow
   • Larry Broadfield

   Original Research Article 23 September 2012 Pages: 845 - 854

   

7. Quality of Life and Utility in Patients with Non-Small Cell Lung Cancer

   • Sabrina Trippoli
   • Monica Vaiani
   • Quality-of-life Study Group of the Master 2 Project in Pharmacoeconomics

   Original Research Article 23 September 2012 Pages: 855 - 863

   

8. Cost-Efficacy Analysis of Fluticasone Propionate versus Zafirlukast in Patients with Persistent Asthma

   • Rogelio Menendez
   • Richard H. Stanford
   • Kathleen Rickard

   Original Research Article 23 September 2012 Pages: 865 - 874

   

9. Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson’s Disease in Japan

   • Takuro Shimbo
   • Kenji Hira
   • Tsuguya Fukui

   Original Research Article 23 September 2012 Pages: 875 - 886